To determine the efficacy and cost of OSA management ( diagnosis and therapeutic decision making ) using ( 1 ) PSG for all patients ( PSG arm ) ; ( 2 ) HRP for all patients ( HRP arm ) ; and ( 3 ) HRP for a subsample of patients with high clinical probability of being treated with continuous positive airway pressure ( CPAP ) and PSG for the remainder ( elective HRP arm ) .